Dr. Maron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Avenue Louis Pasteur
Boston, MA 02115Phone+1 617-525-4803
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2008 - 2011
Boston University Medical CenterResidency, Internal Medicine, 2003 - 2005
The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2025
MD State Medical License 2023 - 2025
NH State Medical License 2024 - 2024
American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study Start of enrollment: 2015 Sep 01
- Pulmonary Hemodynamics During Exercise - Research Network Start of enrollment: 2018 Dec 01
Roles: Contact
Publications & Presentations
PubMed
- Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertension.Geoff A Strange, Bradley A Maron, Katarina Zeder, Yih-Kai Chan, Alexander Chen
Journal of Global Health. 2025-03-21 - Non-canonical lysosomal lipolysis drives mobilization of adipose tissue energy stores with fasting.G V Naveen Kumar, Rui-Sheng Wang, Ankit X Sharma, Natalie L David, Tânia Amorim
Nature Communications. 2025-02-04 - New Kids on the Block: Estimating Use of Next-generation Gram-negative Antibiotics Across Greater Than 700 Hospitals in the United States.Anthony D Harris, Katherine E Goodman, Lisa Pineles, Morgan Walker, Jacqueline T Bork
Open Forum Infectious Diseases. 2025-02-01
Lectures
- A Panoply of Perspectives on Pulmonary Hypertension: Patients Practitioners and Political Advocates2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Co-Moderator: Plain Spoken Perspectives on Pulmonary Hypertension2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients With PAH2013 International Conference, Philadelphia, Pennsylvania, USA
- Join now to see all
Press Mentions
Canadian Wildfire Pollution Negatively Impacted Eastern US Residents’ Lungs, HeartJanuary 7th, 2025- Smoke from Canadian Wildfires Leads to Surge in Heart and Lung Problems in the U.S.December 14th, 2024
- Exposure to Remote Wildfire Smoke Drifting Across the US Linked to Increased Medical Visits for Heart and Lung ProblemsDecember 13th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
